Wang et al. confirmed from in vivo and in vitro experiments that the upregulation of OIP5 promotes the proliferation, metastasis and drug resistance progression of bladder cancer, and it has become a potential therapeutic target and biomarker of bladder cancer prognosis [25]. Here, OIP5 is linked to urinary bladder carcinoma.